NCT03969823 2025-05-15
Whole Genomic Landscape of Advanced EGFR-mutant NSCLC
Seoul National University Hospital
Phase NA Active not recruiting
Clinical Trials
4 trialsNCT06709274 2024-11-29
MOTION-NSCLC
Guangdong Association of Clinical Trials
Phase NA Not yet recruiting
NCT05583409 2022-10-17
SBRT Combined With Osimertinib Compared With Osimertinib for Stage IV NSCLC
Tongji Hospital
Phase NA Unknown
NCT04816838 2021-08-25
A Window of Opportunity Study for Investigating Drug Tolerant Persister (DTP) to Neoadjuvant Osimertinib in Resectable Non-small Cell Lung Cancer (NSCLC) Harbouring EGFR Mutations
Yonsei University
Phase NA Unknown